FDA Approval Updates Enjaymo Indication for Cold Agglutinin Disease
Enjaymo is an immunoglobulin G subclass 4 monoclonal antibody.
Diagnosis & Disease Information
Jesduvroq Approved for Anemia of CKD in Patients on Dialysis
Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
Erythropoietin Not Associated With Increased Stroke Risk in Hemodialysis
The factors that may account for any excess stroke risk among ESA users remain unclear.
Iron Deficiency Without Anemia Common in Peritoneal Dialysis Population
Iron deficiency associates with adverse outcomes in patients on peritoneal dialysis, regardless of anemia status.
Anemia Increases Dementia Risk in CKD
The association is revealed in a study of more 444,000 US veterans with new-onset chronic kidney disease.
FDA Panel Votes on Daprodustat for Anemia of Chronic Kidney Disease
The NDA was supported by data from the ASCEND clinical program, which included dialysis and nondialysis patients.
Ticagrelor Does Not Meet Endpoint Compared With Placebo in Treatment of Pediatric Sickle Cell Disease
Researchers sought to determine whether ticagrelor would improve outcomes in treating patients with SCD.
Sexually Violent Trauma Linked With Pain in Patients With Sickle Cell Disease
Researchers sought to determine whether there may be a link between sexually violent trauma and chronic pain in SCD.
Unusual Cause of Chest, Abdominal Pain in Teen Following ACL Repair
A 17-year-old Black adolescent presents with a 1-day history of acute-onset abdominal pain, palpitations, and anemia. Can you make the diagnosis?
Bifunctional Biologic Gets Orphan Drug Status for Paroxysmal Nocturnal Hemoglobinuria
KP104 is a bifunctional, first-in-class biologic that works by selectively inhibiting the alternative and terminal pathways in the complement system.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...